What caused the volume spike in BMY.SW stock today?

Intraday volume jumped to **500** from an avg **22**, likely due to a liquidity event or momentum selling. No direct company release was quoted; traders should watch order flow and newsfeeds for confirmed catalysts.

What is Meyka AI's 12-month forecast for BMY.SW stock?

Meyka AI's forecast model projects **CHF 39.34** over 12 months, implying **-7.53%** from **CHF 42.54**. Forecasts are model outputs and not guarantees.

How should traders manage risk after the BMY.SW volume spike?

Short-term traders should place tight stops and watch **CHF 42.54** as immediate support and **CHF 43.75** as resistance. Limit position sizes after high relVolume and confirm trades with order-book depth.

Is BMY.SW stock a buy after today’s drop?

Meyka AI rates BMY.SW **B+ (73.46)** with a BUY suggestion, but investors must weigh leverage and pipeline risks. Consider valuation, dividend yield **3.50%**, and upcoming earnings before adding exposure.

CH Stocks

CHF 42.54 volume spike: BMY.SW (Bristol-Myers) on SIX 25 Feb 2026, watch support

ByHuzaifa Zahoor February 25, 2026February 25, 2026

A sharp intraday volume spike pushed BMY.SW stock to CHF 42.54 on the SIX market on 25 Feb 2026, down 4.40% from the previous close. Volume hit 500 shares versus an average of 22, a relative volume of 22.73x, signalling outsized trading interest today. The move follows weakness from broader healthcare peers and a negative technical read on short-term momentum. Traders should watch the immediate support near CHF 42.54 and the 50-day average at CHF 43.75 for clues to next intraday direction.